Cetirizine, an H1-receptor antagonist, suppresses the expression of macrophage migration inhibitory factor: Its potential anti-inflammatory action

Clinical and Experimental Allergy

Volumn 34, Issue 1, 2004, Pages 103-109

  Shimizu, T ^a   Nishihira, J ^a   Watanabe, H ^a   Abe, R ^a   Ishibashi, T ^a   Shimizu, H ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cetirizine; Chemokine; Eosinophil; Interleukin 8; Macrophage migration inhibitory factor

Indexed keywords

CETIRIZINE; EOTAXIN; HISTAMINE H1 RECEPTOR ANTAGONIST; INTERCELLULAR ADHESION MOLECULE 1; MACROPHAGE INFLAMMATORY PROTEIN 2; MACROPHAGE MIGRATION INHIBITION FACTOR;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIA; HUMAN; HUMAN CELL; IN VIVO STUDY; INFLAMMATION; KERATINOCYTE; LEUKOCYTE; MALE; MOUSE; NEUTROPHILIA; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAGWEED POLLEN; SKIN ALLERGY;

ALLERGENS; AMBROSIA; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CETIRIZINE; CHEMOKINES, CC; EOSINOPHILIA; HISTAMINE H1 ANTAGONISTS; HUMANS; INTERLEUKIN-8; KERATINOCYTES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MICE; MICE, INBRED BALB C; MONOKINES; NEUTROPHILS; POLLEN;

EID: 0842334821     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2004.01836.x     Document Type: Article

References (33)

1. Sheffer AL, Samuels LL. Cetirizine: antiallergic therapy beyond traditional H1 antihistamines. J Allergy Clin Immunol 1990; 86:1040-6.
2. Spencer CM, Noble S. Cetirizine: a review of its use in children with allergic disorders. Paediatr Drugs 1999; 1:51-73.
3. Fadel LR, Herpin-Richard N, Rihoux JP, Henocq E. Inhibitory effect of cetirizine 2HCl on eosinophil migration in vivo. Clin Allergy 1987; 17:373-9.
4. Leprevost C, Capron N, De Vos C, Tomassimi M, Capron A. Inhibition of eosinophil chemotaxis by a new anti-allergic compound (cetirizine). Int Arch Allergy Appl Immunol 1988; 87:9-13.
5. Charlesworth EN, Kagey-Sobotka A, Norman PS, Lichenstein LM. Effect of cetirizine on mast cell mediator release and cellular traffic during the cutaneous late phase reaction. J Allergy Clin Immunol 1989; 83:905-12.
6. Albanesi C, Pastore S, Fanales-Belasio E, Girolomoni G. Cetirizine and hydrocortisone differentially regulate ICAM-1 expression and chemokine release in cultured human keratinocytes. Clin Exp Allergy 1998; 28:101-9.
7. Bloom BR, Bennett B. Mechanism of reaction in vivo associated with delayed-type hypersensitivity. Science 1966; 153:80-2.
8. Bernhagen J, Bacher M, Calandra T, Metz CN, Doty SB, Donnelly T, Bucala R. An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J Exp Med 1996; 183:277-82.
9. Shimizu T, Abe R, Ohkawara A, Mizue Y, Nishihira J. Macrophage migration inhibitory factor is an essential immunoregulatory cytokine in atopic dermatitis. Biochem Biophy Res Commun 1997; 240:173-8.
10. Shimizu T, Abe R, Ohkawara A, Nishihira J. Increased production of macrophage migration inhibitory factor (MIF) by PBMCs of atopic dermatitis. J Allergy Clin Immunol 1999; 104:659-64.
11. Yamaguchi E, Nishihira J, Shimizu T et al. Macrophage migration inhibitory factor (MIF) in bronchial asthma. Clin Exp Allergy 2000; 30:1244-9.
12. Rossi AG, Haslett C, Hirani N et al. Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF): potential role in asthma. J Clin Invest 1998; 101:2869-74.
13. Calandra T, Bernhagen J, Mitchell RA, Bucala R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 1994; 179:1895-902.
14. Donnelly SC, Haslett C, Reid PT et al. Regulatory role for macrophage migration. Inhibitory factor in acute respiratory distress syndrome. Nat Med 1997; 3:320-3.
15. Arnold R, Rihoux J, Konig W. Cetirizine counter-regulates interleukin-8 release from human epithelial cells. Clin Exp Allergy 1999; 29:1681-91.
16. Jinquan T, Reimert CM, Deleuran B, Zachariae C, Simonsen C, Thestrup-Pderson K. Cetirizine inhibits the in vitro and ex vivo chemotactic response of T lymphocytes and monocytes. J Allergy Clin Immunol 1995; 95:979-86.
17. Kaneko M, Hitoshi Y, Takatsu K, Mitsumoto S. Role of interleukin-5 in local accumulation of eosinophils in mouse allergic peritonitis. Int Arch Allergy Appl Immunol 1991; 96:41-5.
18. Abe R, Shimizu T, Ohkawara A, Nishihira J. Enhancement of macrophage migration inhibitory factor (MIF) expression in injured epidermis and cultured fibroblasts. Biochim Biophys Acta 2000; 1500:1-9.
19. Yoshii H, Fukata-Yamazaki Y, Yamamoto K, Yago H, Yanagihara Y, Okudaira H. A complex of histamine/mouse gamma-globulin preferentially inhibits allergen-induced peritoneal accumulation of eosinophils, but not neutrophils, in mice. J Allergy Clin Immunol 1997; 100:809-16.
20. Walsh GM. The anti-inflammatory effects of cetirizine. Clin Exp Allergy 1994; 24:81-5.
21. Michel L, De Vos C, Rihoux JP, Burtin C, Benveniste J, Dubertret L. Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAF-acether release and eosinophil recruitment in human skin. J Allergy Clin Immunol 1988; 82:101-9.
22. Zuany-Amorim C, Leduc D, Vargaftig BB, Pretolani M. Characterization and pharmacological modulation of antigen-induced peritonitis in actively sensitized mice. Br J Pharmacol 1993; 110:917-24.
23. Inagaki N, Nagao M, Nakamura N et al. Evaluation of anti-scratch properties of oxatomide and epinastine in mice. Eur J Pharmacol 2000; 400:73-9.
24. Thomson L, Blaylock MG, Sexton DW, Campbell A, Walsh GM. Cetirizine and levocetirizine inhibit eotaxin-induced eosinophil transendothelial migration through human dermal or lung microvascular endothelial cells. Clin Exp Allergy 2002; 32: 1187-92.
25. Pasquale CP, de Silva PMR, Lima MCR et al. Suppression by cetirizine of pleurisy triggered by antigen in actively sensitized rats. Eur J Pharmacol 1992; 223:9-14.
26. Köller M, Hilger RA, Rihoux JP, König W. Cetirizine exerts antinflammatory effects on human neutrophils. Int Arch Allergy Immunol 1996; 110:52-6.
27. Huang XR, Chun Hui CW, Chen YX et al. Macrophage migration inhibitory factor is an important mediator in the pathogenesis of gastric inflammation in rats. Gastroenterology 2001; 121:619-30.
28. Shimizu T, Ohkawara A, Nishihira J, Sakamoto W. Identification of macrophage migration inhibitory factor (MIF) in human skin and its immunohistochemical localization. FEBS Lett 1996; 381:188-202.
29. Leurs R, Church MK, Taglialatela M. H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects. Clin Exp Allergy 2002; 32:489-98.
30. Shimizu T, Abe R, Nakamura H, Ohkawara A, Suzuki M, Nishihira J. High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis. Biochem Biophy Res Commun 1999; 264:751-8.
31. Mitchell RA, Metz CN, Peng T, Bucala R. Sustaineed mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF): regulatory role in cell proliferation and glucocorticoid action. J Biol Chem 1999; 274:18100-6.
32. Cagnoni F, Oddera S, Semino C, Mincarini M, Melioli G, Canonica GW. Cetirizine-induced downregulation of airway fibroblast proliferation and function: a rationale for a different approach to allergy treatment? Immunol Lett 2000; 72:31-4.
33. Oppenheim JJ, Zacharide COC, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene 'intercrine' cytokine family. Ann Rev Immunol 1991; 9:617-48.